Colorectal Cancer Treatment Market Analysis

  • Report ID: 3003
  • Published Date: Dec 24, 2024
  • Report Format: PDF, PPT

Colorectal Cancer Treatment Segmentation

The market is segmented on the basis of treatment type into surgery, chemotherapy, immunotherapy, radiotherapy, targeted therapy, ablation and others, out of which, the targeted therapy segment is anticipated to grab the largest share by the end of 2021 on account of technological advancements and better efficiency of targeted therapy than other therapies, for the treatment of colorectal cancer. Moreover, there is a large availability of prominent targeted therapies, which is also projected to contribute to the growth of the segment during the forecast period.

On the basis of end-user, the general medical & surgical hospitals segment in the global colorectal cancer treatment market is projected to grow with a significant CAGR over the forecast period. The growth of the segment can be attributed to the fact that general medical & surgical hospitals possess well-developed healthcare infrastructure for the diagnosis and treatment of colorectal cancer. 

Our in-depth analysis of the global market includes the following segments:

           By Treatment Type

  • Surgery
  • Chemotherapy
  • Immunotherapy
  • Radiotherapy
  • Targeted Therapy
  • Ablation
  • Others

             By End-User

  • General Medical & Surgical Hospitals
  • Specialty Hospitals
  • Clinics
  • Others
 

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of colorectal cancer treatment is assessed at USD 20.8 billion.

Colorectal Cancer Treatment Market size was valued at USD 20.08 billion in 2024 and is expected to reach USD 34.28 billion by 2037, registering around 4.2% CAGR during the forecast period i.e., between 2025-2037.

Asia Pacific industry is estimated to account for largest revenue share by 2037, owing to increasing awareness about colorectal cancer and need to develop innovative cancer treatment solutions in the region.

The major players in the market are Genentech, Inc., Eli Lilly and Company, F. Hoffman-La Roche AG, and Bristol Myers Squibb, among others.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos